![Kim Stratton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kim Stratton
Direttore/Membro del Consiglio presso RECORDATI
Patrimonio netto: 60 956 $ in data 31/10/2024
Profilo
Kim Stratton currently works at Centogene GmbH, as Chief Executive Officer from 2022, Recordati SpA, as Non-Executive Director from 2021, European Federation of Pharmaceutical Industries & Assns, as Director, Vifor Pharma Management AG, as Director, and Novonesis A, as Independent Director from 2024.
Ms. Stratton also formerly worked at Strategic Partners A, as Chief Executive Officer from 2019 to 2020, Centogene NV, as Chief Executive Officer & Managing Director from 2021 to 2023, Vifor Pharma AG, as Independent Director, Novozymes A, as Independent Director from 2017 to 2023, Bristol Myers Squibb Co., as Head-Marketing, AstraZeneca PLC, as Head-United Kingdom Respiratory Business, Novartis AG, as Head-Group Country Management & External Affairs from 2010 to 2013, GlaxoSmithKline Investments Pty Ltd., as Sales Representative, Novartis UK Ltd., as Chief Operating Officer, and Shire International GmbH, as Head-International Commercial.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CENTOGENE NV
1,2% | 15/05/2024 | 348 322 ( 1,2% ) | 60 956 $ | 31/10/2024 |
Ultime notizie su Kim Stratton
Posizioni attive di Kim Stratton
| Società | Posizione | Inizio |
|---|---|---|
| RECORDATI | Direttore/Membro del Consiglio | 16/12/2021 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Direttore/Membro del Consiglio | - |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Direttore/Membro del Consiglio | - |
Centogene GmbH
 Centogene GmbH BiotechnologyHealth Technology Part of Centogene NV, Centogene GmbH is a German biotechnology company. The company is based in Rostock, Germany. The company was founded in 2006. Kim Stratton has been the CEO of the company since 2022. | Amministratore Delegato | 01/01/2022 |
Precedenti posizioni note di Kim Stratton
| Società | Posizione | Fine |
|---|---|---|
| STRATEGIC PARTNERS A/S | Amministratore Delegato | 10/12/2020 |
| NOVARTIS AG | Public Communications Contact | 01/03/2013 |
| CENTOGENE N.V. | Amministratore Delegato | - |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Direttore operativo | - |
Shire International GmbH
 Shire International GmbH Medical DistributorsDistribution Services Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a Swiss company that wholesales pharmaceutical products. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| NOVARTIS AG | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| STRATEGIC PARTNERS A/S | Health Technology |
| RECORDATI | Health Technology |
| CENTOGENE N.V. | Commercial Services |
| Aziende private | 8 |
|---|---|
Glaxosmithkline Investments Pty Ltd.
 Glaxosmithkline Investments Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Investments Pty Ltd. is a company based in Boronia, Australia. The Australian company was founded in 2001. | Health Technology |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Process Industries |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland. | Health Technology |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
Shire International GmbH
Shire International GmbH Medical DistributorsDistribution Services Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a Swiss company that wholesales pharmaceutical products. | Distribution Services |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Health Technology |
Novartis UK Ltd.
Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Health Technology |
Centogene GmbH
Centogene GmbH BiotechnologyHealth Technology Part of Centogene NV, Centogene GmbH is a German biotechnology company. The company is based in Rostock, Germany. The company was founded in 2006. Kim Stratton has been the CEO of the company since 2022. | Health Technology |
- Borsa valori
- Insiders
- Kim Stratton
